Pneumologia

Fibrose Pulmonar Idiopática

Antifibrotic therapy (nintedanib, pirfenidone) and lung transplant evaluation.

Opções de Tratamento

Centros Recomendados

$2,500

A partir de

7-21 dias

Espera Típica

Planos de Tratamento para Fibrose Pulmonar Idiopática

Compare opções baseadas em evidências nos principais hospitais chineses — preços transparentes, tempos de espera e recuperação.

Plano Principal

Pirfenidone Antifibrotic Therapy (Annual)

Daily oral antifibrotic with quarterly LFT and PFT monitoring.

Tempo de Espera

5-7 days

Internação

Annual maintenance

Recuperação

Outpatient

Preço Estimado

Approx. $3,500/year

Ver Introdução Detalhada — Procedimento, Comparação de Preços e Mais

Comparação de Preços: China vs EUA

🇨🇳 China

$2,500

🇺🇸 EUA

$13,750+

Economize até $11,250 por tratamento

Etapas do Procedimento

Pre-treatment: HRCT chest + PFTs (FVC, DLCO) + 6MWT + ILD multidisciplinary review

Baseline LFTs + photosensitivity assessment

Pirfenidone titration: Week 1: 267mg TID, Week 2: 534mg TID, Week 3+: 801mg TID

Take with food to reduce GI side effects

Photosensitivity protection: strict sunscreen + sun avoidance

Monthly LFT monitoring for first 6 months

Every 3-6 months: FVC, DLCO, 6MWT

Continue indefinitely if tolerated and effective

What is Pirfenidone for IPF?

An oral antifibrotic drug that slows the progression of idiopathic pulmonary fibrosis by inhibiting multiple fibrotic pathways. Combined with comprehensive ILD care, it extends life expectancy and preserves lung function.

Why China?

Cost (annual): $2,500-$5,500 (domestic) vs. $95,000-$120,000 in the US
Domestic production: Chinese-made pirfenidone + nintedanib at fraction of Western prices
ILD expertise: China-Japan Friendship Hospital is Asia's leading ILD center
Comprehensive management: Integrated pulmonary rehab + O2 therapy + transplant evaluation

Who is a candidate?

Confirmed IPF (UIP pattern on HRCT or biopsy)
FVC 50-80% predicted (disease-modifying window)
ECOG 0-2
Unexplained progressive fibrosing ILD (now also indicated)

Outcomes

FVC decline reduction: ~50%. Disease progression slowing: significant. Median survival extension: 1-2 years vs untreated. Common adverse effects: GI upset (30%), photosensitivity (20%) — usually manageable.

Agendar Consulta Gratuita WhatsApp

Os preços são faixas indicativas em USD baseadas nas tarifas publicadas. A cotação final depende dos seus registros médicos e hospital selecionado — solicite uma estimativa personalizada gratuita.